Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
A concise comparison answering Which Performs Better Index Fund Or Target Date Fund, focusing on performance, risk, and long-term suitability.
25,681 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
A new $6,000 senior tax deduction comes with an income-based phase-out that can trim or erase relief for those who wo...
Mortgage rates remain above 6.7% amid persistent inflation concerns and a solid jobs market, with housing demand show...
Broadcom just cratered 16% in a month, triggering a much-needed debate among investors: Is this a buying dip or the s...
When a biotech deal moves a small cap, it can set the tone for the whole sector. This story explains what happened wi...
Bitcoin briefly dipped below $65,000 on Sunday as tariff headlines surged, but the crypto recovered Monday amid a bro...
Bitcoin has faced a sharp decline, leaving investors wondering about a villain behind the fall. This article separate...
Beyond Meat has faced a sharp drop in price, flirting with Nasdaq's $1 threshold. This piece breaks down what a rever...
A $130,000 insider sale at CorVel raises questions for investors. This guide breaks down what the move could mean, ho...
Linkhome is accelerating its AI-driven lending ambitions by acquiring Mortgage One Group. The deal, slated to close b...
Rising gas costs push Gen Z to curb discretionary spending, nudging cosmetics brands to cut prices and rethink produc...
Drones and government funding chatter are reshaping investor sentiment. Ondas is at the center of the action, with ot...